21 CFR 1301.51 - Modification in registration

Cite as21 CFR 1301.51
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
23 practice notes
  • Annicol Marrocco, M.D.; Decision and Order
    • United States
    • Federal Register May 19, 2015
    • May 19, 2015
    ...address'' and that she violated DEA regulations by ``failing to keep her registered address current with the'' Agency. Id. (citing 21 CFR 1301.51). Respondent timely requested a hearing on the allegations; the matter was then placed on the docket of the Office of Administrative Law Judges a......
  • Mark P. Koch, D.O.; Decision and Order
    • United States
    • Federal Register April 03, 2014
    • April 3, 2014
    ...I reject the ALJ's reasoning that there is no such duty under federal law. In reaching her conclusion, the ALJ relied entirely on 21 CFR 1301.51 and reasoned that the Agency's ``regulations do not explicitly define a registrant's duty to notify the DEA of a change in address.'' R.D. at 52. ......
  • Disposal of Controlled Substances
    • United States
    • Federal Register December 21, 2012
    • December 21, 2012
    ...manufacturer, distributor, reverse distributor, or retail pharmacy must apply for a modification to their registration in accordance with 21 CFR 1301.51, which DEA is proposing to revise in order to reflect these changes. Upon DEA approval of this modification in registration, each authoriz......
  • Margy Temponeras, M.D.; Decision and Order
    • United States
    • Federal Register August 01, 2012
    • August 1, 2012
    ...\30\ --------------------------------------------------------------------------- \27\ 21 U.S.C. 822(a)(2). \28\ 21 U.S.C. 822(e), 827(g); 21 CFR 1301.51. \29\ See 21 CFR 1301.51. \30\ 21 CFR 1306.06 --------------------------------------------------------------------------- Ohio law require......
  • Request a trial to view additional results
3 cases
  • Wedgewood Village Pharmacy v. D.E.A., No. 06-1156.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • December 11, 2007
    ...new facility in Swedesboro, New Jersey and DEA declined to allow it to modify its registration to reflect its new address pursuant to 21 C.F.R. § 1301.51. See ALJ Hr'g Tr. 35-41 (JA 12-18) (discussing Wedgewood's inability to handle controlled substances following DEA's denial of Wedgewood'......
  • Wedgewood Village Pharmacy, Inc. v. Ashcroft, Civil Action No. 03-5242(JBS).
    • United States
    • United States District Courts. 3th Circuit. United States District Courts. 3th Circuit. District of New Jersey
    • December 15, 2003
    ...location where controlled substances are manufactured, distributed, imported, exported, or dispensed by a person." Id. Pursuant to 21 C.F.R. § 1301.51, a simple method is provided for notifying DEA of a prospective change of address. Any registrant may apply to modify his registration in or......
  • Volkman v. U.S. Drug Enforcement Admin., No. 08-3802.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (6th Circuit)
    • June 3, 2009
    ...appeal as an application for a new registration, which is evaluated by the same criteria as a revocation of an existing registration. 21 C.F.R. § 1301.51. --------------- ...

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT